 | View in Programme [PDF] |
Available with new instructors!
Tutorial 1 - Highlights of the Implementation of the New Pharmacovigilance Legislation with Regard to Adverse Reaction Reporting Rules, Use of New International Standards and Signal Management in Eudravigilance
Tutorial 2 - Analysis of Safety Data from Clinical Trials
Tutorial 3 - Update on Practical Work with Variations Under the Revised Regulation
Tutorial 4 - Introduction to EU Mecical Device Regulation
Tutorial 5 - Recent and Current Developments in Pharmaceutical Law
Tutorial 6 - CANCELLED - Incentives for Drug Development
NEW!Tutorial 7 - The Dialogue and Negotiation Process Between Applying Company and the Paediatric Committee of the European Medicines Agency
Tutorial 8 - Health Technology Assessment (HTA) of Drugs and Medical Devices
Tutorial 9 - The European Qualified Person for Pharmacovigilance; Everything you ever wanted to know but were afraid to ask
Tutorial 10 - Non-Clinical Safety Assessment in Global Pharmaceutical Development
Tutorial 11 - Interactions Between Regulatory and Intellectual Property, Privacy and Product Liability
Tutorial 12 - Development Safety Update Report (DSUR) Kick-Off in 2011 - And now in practice
Tutorial 13 - Technology Transfer for Biopharmaceuticals
Tutorial 14 - Pharmacovigilance Audits and Inspections
Tutorial 15 - Coding with Confidence
Tutorial 16 - Understanding Translational Medicine
Tutorial 17 - Creating Compliant Clinical Study Reports (CSRS) for the EU and US
Tutorial 18 - Roundtable Discussion (Special Fee €200 + VAT): GCP Inspection and Audit Findings
No comments:
Post a Comment